Inside the Regulatory Maze: What It Actually Takes to Get a Cannabis Drug FDA-Approved
Comments Off on Inside the Regulatory Maze: What It Actually Takes to Get a Cannabis Drug FDA-Approved
April 16, 2026
Cannabis botanical drug development faces unique regulatory challenges that complicate FDA approval. The dual oversight by the FDA and DEA imposes significant hurdles for developers. Understanding these complexities is essential for advancing cannabinoid…
The Coming Divide in Cannabis: Why the U.S. Market Remains Out of Reach for Global Operators
Comments Off on The Coming Divide in Cannabis: Why the U.S. Market Remains Out of Reach for Global Operators
March 5, 2026
Cannabinoid research barriers in the U.S. create challenges for developing evidence-based cannabis medicines. Federal scheduling under the Controlled Substances Act fragments the regulatory environment. This limits patient access to clinically validated…